Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 134

1.

Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy.

Beeler JA, Eichelberger MC.

Microb Pathog. 2013 Feb;55:9-15. doi: 10.1016/j.micpath.2012.11.013. Epub 2012 Dec 13. Review.

PMID:
23247146
[PubMed - indexed for MEDLINE]
2.

[Immunisation: leaps into the future. The flu virus and syncytial respiratory virus: strategies for active immunisation].

Mato Chaín G, Mariano Lázaro A, Rodríguez Caravaca G, Fereres Castiel J.

Aten Primaria. 2002 Sep 15;30(4):243-7. Spanish. No abstract available.

PMID:
12237030
[PubMed - indexed for MEDLINE]
Free Article
3.

The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines.

Wright PF, Karron RA, Belshe RB, Shi JR, Randolph VB, Collins PL, O'Shea AF, Gruber WC, Murphy BR.

Vaccine. 2007 Oct 16;25(42):7372-8. Epub 2007 Aug 28.

PMID:
17868959
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Immunopathology of RSV infection: prospects for developing vaccines without this complication.

van Drunen Littel-van den Hurk S, Mapletoft JW, Arsic N, Kovacs-Nolan J.

Rev Med Virol. 2007 Jan-Feb;17(1):5-34. Review.

PMID:
17004293
[PubMed - indexed for MEDLINE]
5.

Venezuelan equine encephalitis virus replicon particles encoding respiratory syncytial virus surface glycoproteins induce protective mucosal responses in mice and cotton rats.

Mok H, Lee S, Utley TJ, Shepherd BE, Polosukhin VV, Collier ML, Davis NL, Johnston RE, Crowe JE Jr.

J Virol. 2007 Dec;81(24):13710-22. Epub 2007 Oct 10.

PMID:
17928349
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Advances in and the potential of vaccines for respiratory syncytial virus.

Jorquera PA, Oakley KE, Tripp RA.

Expert Rev Respir Med. 2013 Aug;7(4):411-27. doi: 10.1586/17476348.2013.814409. Review.

PMID:
23964629
[PubMed - indexed for MEDLINE]
7.

Respiratory syncytial virus and influenza virus infections: observations from tissues of fatal infant cases.

Welliver TP, Reed JL, Welliver RC Sr.

Pediatr Infect Dis J. 2008 Oct;27(10 Suppl):S92-6. doi: 10.1097/INF.0b013e318168b706.

PMID:
18820587
[PubMed - indexed for MEDLINE]
8.

Live-attenuated respiratory syncytial virus vaccines.

Karron RA, Buchholz UJ, Collins PL.

Curr Top Microbiol Immunol. 2013;372:259-84. doi: 10.1007/978-3-642-38919-1_13.

PMID:
24362694
[PubMed - indexed for MEDLINE]
9.

Current progress on development of respiratory syncytial virus vaccine.

Chang J.

BMB Rep. 2011 Apr;44(4):232-7. doi: DOI 10.5483/BMBRep.2011.44.4.232. Review.

PMID:
21524347
[PubMed - indexed for MEDLINE]
Free Article
10.

Respiratory syncytial virus: reverse genetics and vaccine strategies.

Collins PL, Murphy BR.

Virology. 2002 May 10;296(2):204-11. Review. No abstract available.

PMID:
12069519
[PubMed - indexed for MEDLINE]
Free Article
11.

Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years.

Collins PL, Melero JA.

Virus Res. 2011 Dec;162(1-2):80-99. doi: 10.1016/j.virusres.2011.09.020. Epub 2011 Sep 22. Review.

PMID:
21963675
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands.

Shafique M, Wilschut J, de Haan A.

Vaccine. 2012 Jan 11;30(3):597-606. doi: 10.1016/j.vaccine.2011.11.054. Epub 2011 Nov 24.

PMID:
22120195
[PubMed - indexed for MEDLINE]
13.

Enhancement of mucosal and cellular immune response in mice by vaccination with respiratory syncytial virus DNA encapsulated with transfersome.

Xu J, Ding Y, Yang Y.

Viral Immunol. 2008 Dec;21(4):483-9. doi: 10.1089/vim.2008.0044.

PMID:
19115938
[PubMed - indexed for MEDLINE]
14.

Progress in the development of respiratory syncytial virus and parainfluenza virus vaccines.

Durbin AP, Karron RA.

Clin Infect Dis. 2003 Dec 15;37(12):1668-77. Epub 2003 Nov 20.

PMID:
14689350
[PubMed - indexed for MEDLINE]
Free Article
15.

Clinical and epidemiologic features of respiratory syncytial virus.

Hall CB, Simőes EA, Anderson LJ.

Curr Top Microbiol Immunol. 2013;372:39-57. doi: 10.1007/978-3-642-38919-1_2.

PMID:
24362683
[PubMed - indexed for MEDLINE]
16.

Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children.

Belshe RB, Newman FK, Anderson EL, Wright PF, Karron RA, Tollefson S, Henderson FW, Meissner HC, Madhi S, Roberton D, Marshall H, Loh R, Sly P, Murphy B, Tatem JM, Randolph V, Hackell J, Gruber W, Tsai TF.

J Infect Dis. 2004 Dec 15;190(12):2096-103. Epub 2004 Nov 8.

PMID:
15551207
[PubMed - indexed for MEDLINE]
Free Article
17.

Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys.

Tang RS, MacPhail M, Schickli JH, Kaur J, Robinson CL, Lawlor HA, Guzzetta JM, Spaete RR, Haller AA.

J Virol. 2004 Oct;78(20):11198-207.

PMID:
15452239
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

The cotton rat Sigmodon hispidus model of respiratory syncytial virus infection.

Boukhvalova MS, Blanco JC.

Curr Top Microbiol Immunol. 2013;372:347-58. doi: 10.1007/978-3-642-38919-1_17.

PMID:
24362698
[PubMed - indexed for MEDLINE]
19.
20.

Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB/c mice, with no evidence of immunopathology.

Murawski MR, McGinnes LW, Finberg RW, Kurt-Jones EA, Massare MJ, Smith G, Heaton PM, Fraire AE, Morrison TG.

J Virol. 2010 Jan;84(2):1110-23. doi: 10.1128/JVI.01709-09. Epub 2009 Nov 4.

PMID:
19889768
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk